The Right Support at the Right Time in the Right Way
For Pharma/ Biotech, Medtech/ Diagnostics, Life Sciences and Healthcare
Support
Advisory
Pick the support you need right now from focused ad-hoc Advisory to a long-term program partnership. No matter the support scope, we always focus on impact in everything we do.
Interim Management
We are providing the right interim managers, with the right capabilities for the right duration. Experienced industry and/ or consulting managers join your (virtual) teams and add value from the first day.
Contracting/ outsourcing
Did you define your core capabilities and want to externalize non-core (functional) skills? We will shape and implement a collaboration/ partnership strategy, relying on trusted specialists.
Let’s Chat!
Why Us
Trusted by Past Collaboration Partners
Our experienced advisors have a proven track record of working successfully with clients, former colleagues, freelancers and partner companies, often over decades in changing settings.
Clients, throughout their careers/ companies
Former colleagues, as freelancers and clients
Freelancers, as Interim Managers and clients
Partner companies, with engagement-driven roles
Learn More
Insights
Weekly Free Business Resources
If you want to receive weekly business resources and news, please subscribe to our insights blog.
Orphan drugs leading the way in patient-centricity
In rare diseases, true patient engagement is critical to every step of a drug's development, from clinical trials and regulatory approval, to patient diagnosis and adherence. Why is that? Because patients with rare diseases (and their families) are essentially the...
BioPharma without borders: A dynamic approach for getting niche specialty care and orphan products to market
The healthcare environment has changed almost beyond recognition in the past decade and this has been well documented. One of the key upshots of the turbulence caused by healthcare reforms, patent cliffs, drying product pipelines, fiscal restraint and a host of other...
Current perspectives on the biopharma go-to-market model
With increasing pressures on healthcare systems, the rise in power of different stakeholders such as payers, patients and policy makers, and the launch of highly specialised/rare treatments, such as personalised medicines, the traditional go-to-market models for...
Almasan AG
The right support for the pharma/ biotech, medtech/ diagnostics, life sciences and healthcare sectors at the right time in the right way: Advisory, Interim Management and Contracting/ Outsourcing.